Combating chemoresistance amongst MYC amplified patients with neuroblastoma and medulloblastoma by inhibiting BRD4-MYC signalling axis (2024–2025)
- Grant type:
- TRI Leading Innovations through New Collaborations Scheme
- Researchers:
-
-
Postdoctoral Research Fellow
Frazer Institute
Faculty of Medicine
Postdoctoral Research Fellow
Frazer Institute
Faculty of Medicine
- Funded by:
- The Trustee for Translational Research Institute Trust